Kueuk 2008.

Methods	Randomisation: computer generated randomisation. Allocation concealment: sealed envelopes. Blinding: triple. Intention to treat analysis: not performed. Power calculation: not performed. Study setting: single centre ‐ Bursa, Turkey. Withdrawals: none. Cancelled cycles: <10%.
Participants	Number of women n= 61 (31 growth hormone, 30 placebo). Inclusion criteria: women who responded poorly to high dose gonadotrophin treatment in their first cycles in the same centre. Cause of subfertility: Not stated.
Interventions	Intervention: growth hormone 12IU sub cutaneous from day 21 of preceding cycle along with GnRHa, until the day of human chorionic gonadotropin. Treatment Protocol: Long GnRHa/FSH/hMG protocol used. Dose of human chorionic gonadotropin: 10000 IU when sat least 1 follicle was > 17mm in diameter.
Outcomes	Clinical pregnancy.
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Adequate sequence generation?	Low risk	Computer generated randomisation
Allocation concealment?	Unclear risk	Sealed envelopes. No details as to whether opaque
Blinding? All outcomes	Low risk	Triple blinded
Free of selective reporting?	Low risk	There is no indication the study has reported outcomes selectively
Free of other bias?	High risk	No adverse effects reported